Trials / Completed
CompletedNCT00661154
Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility Project
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 7 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To determine whether using a radiolabelled analog of 5-FU, \[18F\]-5-fluorouracil, for PET/CT imaging can visually demonstrate differential chemotherapy delivery to known tumor sites before and after administration of bevacizumab and determine the optimal timing of bevacizumab administration to maximize the chemotherapy delivery into the tumor for improved cancer treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bevacizumab | 2-12microCi IV injection |
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2009-07-01
- Completion
- 2010-07-01
- First posted
- 2008-04-18
- Last updated
- 2012-08-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00661154. Inclusion in this directory is not an endorsement.